Press releases
The Spanish biotech company looks for pharma or food companies interested in bringint its products to new markets
AB-Biotics and GlaxoSmithKline sign an agreement to promote the test Neurofarmagen in Brazil
The Spanish biotech company traded on the MAB partners with GlaxoSmithKline to promote its genetic analysis in the Latin American giant market, with 1 million potential beneficiaries
“AB-Dentis”, developed by the Spanish biotech company, has bactericidal activity against the most common oral pathogens. The company has signed a distribution agreement with the Danish firm CMS Dental to market the product worldwide
AB-Biotics closes €5-millions round of funding
These resources will go to boost international expansion started this year by the Spanish biotech company traded on the Alternative Stock Market (MAB). Pharmaceutical company Almirall has entered as a new shareholder, investing €1 million
